SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-044027
Filing Date
2012-08-09
Accepted
2012-08-09 16:06:35
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v319119_10q.htm 10-Q 462977
2 EXHIBIT 31.1 v319119_ex31-1.htm EX-31.1 10166
3 EXHIBIT 31.2 v319119_ex31-2.htm EX-31.2 9989
4 EXHIBIT 32.1 v319119_ex32-1.htm EX-32.1 4397
5 EXHIBIT 32.2 v319119_ex32-2.htm EX-32.2 4387
  Complete submission text file 0001144204-12-044027.txt   3562211

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20120630.xml EX-101.INS 422345
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20120630.xsd EX-101.SCH 37198
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20120630_cal.xml EX-101.CAL 48311
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20120630_def.xml EX-101.DEF 219829
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20120630_lab.xml EX-101.LAB 320489
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20120630_pre.xml EX-101.PRE 258195
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 121020432
SIC: 2836 Biological Products, (No Diagnostic Substances)